United-Guardian FY2025 net sales down 13% to $10.5M; net income falls to $2.1M ($0.46/share)

UNITED GUARDIAN INC

Net sales $10.5M, down 13% from $12.2M in FY2024; net income $2.1M ($0.46/share) vs $3.3M ($0.71/share) prior year.
Cosmetic ingredient sales declined due to excess inventory at distributor Ashland Specialty Ingredients and weaker China demand.
Pharmaceuticals up 15%, medical lubricants up 4% YoY; Renacidin added to two major pharmacy benefit manager formularies.
Management optimistic about new marketing agreements and distributor efforts to regain market share in coming years.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

UNITED GUARDIAN INC reported FY 2025 results: revenue $10,545,468, net income $2,105,738, EPS $0.46 per share.

Period: FY 2025
Revenue: $10,545,468
Net income: $2,105,738
EPS: $0.46 per share
Result: reported results

Exact text from the filing

United-Guardian Reports 2025 Financial Results HAUPPAUGE, N.Y., March 27, 2026 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) reported that net sales and net income for FY 2025 decreased compared to FY 2024. Net sales for the year decreased by 13% from $12,181,971 in 2024 to $10,545,468 in 2025, generating net income of $3,250,875 ($0.71 per share) in 2024 compared to $2,105,738 ($0.46 per share) in 2025.

View on SEC.gov

39 earnings releases filed in the last 30 days. Browse all earnings releases →

UNITED GUARDIAN INC filing history →

Source: SEC EDGAR

accession 0001171843-26-001972

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.